Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 437 entries
Sorted by: Best Match Show Resources per page
Evaluation of the Impact of National HIV Testing Day - United States, 2011-2014.

MMWR. Morbidity and mortality weekly report

Lecher SL, Hollis N, Lehmann C, Hoover KW, Jones A, Belcher L.
PMID: 27336946
MMWR Morb Mortal Wkly Rep. 2016 Jun 24;65(24):613-8. doi: 10.15585/mmwr.mm6524a2.

Human immunodeficiency virus (HIV) testing is the first step in the continuum of HIV prevention, care, and treatment services, without which, gaps in HIV diagnosis cannot be addressed. National HIV testing campaigns are useful for promoting HIV testing among...

Cite
Lecher SL, Hollis N, Lehmann C, et al. Evaluation of the Impact of National HIV Testing Day - United States, 2011-2014. MMWR Morb Mortal Wkly Rep. 2016;65(24):613-8doi: 10.15585/mmwr.mm6524a2.
Lecher, S. L., Hollis, N., Lehmann, C., Hoover, K. W., Jones, A., & Belcher, L. (2016). Evaluation of the Impact of National HIV Testing Day - United States, 2011-2014. MMWR. Morbidity and mortality weekly report, 65(24), 613-8. https://doi.org/10.15585/mmwr.mm6524a2
Lecher, Shirley Lee, et al. "Evaluation of the Impact of National HIV Testing Day - United States, 2011-2014." MMWR. Morbidity and mortality weekly report vol. 65,24 (2016): 613-8. doi: https://doi.org/10.15585/mmwr.mm6524a2
Lecher SL, Hollis N, Lehmann C, Hoover KW, Jones A, Belcher L. Evaluation of the Impact of National HIV Testing Day - United States, 2011-2014. MMWR Morb Mortal Wkly Rep. 2016 Jun 24;65(24):613-8. doi: 10.15585/mmwr.mm6524a2. PMID: 27336946.
Copy Download .nbib Format: NLM
[HIV pre-exposure prophylaxis in women].

MMW Fortschritte der Medizin

Haberl A.
PMID: 28597264
MMW Fortschr Med. 2017 Jun;159:42-44. doi: 10.1007/s15006-017-9736-9.

No abstract available.

Cite
Haberl A. PrEP: Profitieren Frauen weniger? [HIV pre-exposure prophylaxis in women]. MMW Fortschr Med. 2017;159:42-44doi: 10.1007/s15006-017-9736-9.
Haberl, A. (2017). PrEP: Profitieren Frauen weniger? [HIV pre-exposure prophylaxis in women]. MMW Fortschritte der Medizin, 15942-44. https://doi.org/10.1007/s15006-017-9736-9
Haberl, Annette. "PrEP: Profitieren Frauen weniger?" [HIV pre-exposure prophylaxis in women]. MMW Fortschritte der Medizin vol. 159 (2017): 42-44. doi: https://doi.org/10.1007/s15006-017-9736-9
Haberl A. PrEP: Profitieren Frauen weniger? [HIV pre-exposure prophylaxis in women]. MMW Fortschr Med. 2017 Jun;159:42-44. doi: 10.1007/s15006-017-9736-9. German. PMID: 28597264.
Copy Download .nbib Format: NLM
Reducing mortality in HIV-infected infants and achieving the 90-90-90 target through innovative diagnosis approaches.

Journal of the International AIDS Society

Essajee S, Vojnov L, Penazzato M, Jani I, Siberry GK, Fiscus SA, Markby J.
PMID: 26639120
J Int AIDS Soc. 2015 Dec 02;18:20299. doi: 10.7448/IAS.18.7.20299. eCollection 2015.

INTRODUCTION: Despite significant gains in access to early infant diagnosis (EID) over the past decade, most HIV-exposed infants still do not get tested for HIV in the first two months of life. For those who are tested, the long...

Cite
Essajee S, Vojnov L, Penazzato M, et al. Reducing mortality in HIV-infected infants and achieving the 90-90-90 target through innovative diagnosis approaches. J Int AIDS Soc. 2015;18:20299doi: 10.7448/IAS.18.7.20299.
Essajee, S., Vojnov, L., Penazzato, M., Jani, I., Siberry, G. K., Fiscus, S. A., & Markby, J. (2015). Reducing mortality in HIV-infected infants and achieving the 90-90-90 target through innovative diagnosis approaches. Journal of the International AIDS Society, 1820299. https://doi.org/10.7448/IAS.18.7.20299
Essajee, Shaffiq, et al. "Reducing mortality in HIV-infected infants and achieving the 90-90-90 target through innovative diagnosis approaches." Journal of the International AIDS Society vol. 18 (2015): 20299. doi: https://doi.org/10.7448/IAS.18.7.20299
Essajee S, Vojnov L, Penazzato M, Jani I, Siberry GK, Fiscus SA, Markby J. Reducing mortality in HIV-infected infants and achieving the 90-90-90 target through innovative diagnosis approaches. J Int AIDS Soc. 2015 Dec 02;18:20299. doi: 10.7448/IAS.18.7.20299. eCollection 2015. PMID: 26639120; PMCID: PMC4670838.
Copy Download .nbib Format: NLM
Update on pre-exposure prophylaxis.

Journal watch. AIDS clinical care

Abdool Karim SS.
PMID: 27652425
J Watch AIDS Clin Care. 2011 May;23(5):37-8.

No abstract available.

Cite
Abdool Karim SS. Update on pre-exposure prophylaxis. J Watch AIDS Clin Care. 2011;23(5):37-8
Abdool Karim, S. S. (2011). Update on pre-exposure prophylaxis. Journal watch. AIDS clinical care, 23(5), 37-8.
Abdool Karim, Salim S. "Update on pre-exposure prophylaxis." Journal watch. AIDS clinical care vol. 23,5 (2011): 37-8.
Abdool Karim SS. Update on pre-exposure prophylaxis. J Watch AIDS Clin Care. 2011 May;23(5):37-8. PMID: 27652425.
Copy Download .nbib Format: NLM
Transitioning a Large Scale HIV/AIDS Prevention Program to Local Stakeholders: Findings from the Avahan Transition Evaluation.

PloS one

Bennett S, Singh S, Rodriguez D, Ozawa S, Singh K, Chhabra V, Dhingra N.
PMID: 26327591
PLoS One. 2015 Sep 01;10(9):e0136177. doi: 10.1371/journal.pone.0136177. eCollection 2015.

BACKGROUND: Between 2009-2013 the Bill and Melinda Gates Foundation transitioned its HIV/AIDS prevention initiative in India from being a stand-alone program outside of government, to being fully government funded and implemented. We present an independent prospective evaluation of the...

Cite
Bennett S, Singh S, Rodriguez D, et al. Transitioning a Large Scale HIV/AIDS Prevention Program to Local Stakeholders: Findings from the Avahan Transition Evaluation. PLoS One. 2015;10(9):e0136177doi: 10.1371/journal.pone.0136177.
Bennett, S., Singh, S., Rodriguez, D., Ozawa, S., Singh, K., Chhabra, V., & Dhingra, N. (2015). Transitioning a Large Scale HIV/AIDS Prevention Program to Local Stakeholders: Findings from the Avahan Transition Evaluation. PloS one, 10(9), e0136177. https://doi.org/10.1371/journal.pone.0136177
Bennett, Sara, et al. "Transitioning a Large Scale HIV/AIDS Prevention Program to Local Stakeholders: Findings from the Avahan Transition Evaluation." PloS one vol. 10,9 (2015): e0136177. doi: https://doi.org/10.1371/journal.pone.0136177
Bennett S, Singh S, Rodriguez D, Ozawa S, Singh K, Chhabra V, Dhingra N. Transitioning a Large Scale HIV/AIDS Prevention Program to Local Stakeholders: Findings from the Avahan Transition Evaluation. PLoS One. 2015 Sep 01;10(9):e0136177. doi: 10.1371/journal.pone.0136177. eCollection 2015. PMID: 26327591; PMCID: PMC4556643.
Copy Download .nbib Format: NLM
Secondary schooling might be as good an HIV investment as male circumcision.

The Lancet. Global health

Remme M, Watts C, Heise L, Vassall A.
PMID: 26385294
Lancet Glob Health. 2015 Oct;3(10):e591. doi: 10.1016/S2214-109X(15)00167-9.

No abstract available.

Cite
Remme M, Watts C, Heise L, et al. Secondary schooling might be as good an HIV investment as male circumcision. Lancet Glob Health. 2015;3(10):e591doi: 10.1016/S2214-109X(15)00167-9.
Remme, M., Watts, C., Heise, L., & Vassall, A. (2015). Secondary schooling might be as good an HIV investment as male circumcision. The Lancet. Global health, 3(10), e591. https://doi.org/10.1016/S2214-109X(15)00167-9
Remme, Michelle, et al. "Secondary schooling might be as good an HIV investment as male circumcision." The Lancet. Global health vol. 3,10 (2015): e591. doi: https://doi.org/10.1016/S2214-109X(15)00167-9
Remme M, Watts C, Heise L, Vassall A. Secondary schooling might be as good an HIV investment as male circumcision. Lancet Glob Health. 2015 Oct;3(10):e591. doi: 10.1016/S2214-109X(15)00167-9. PMID: 26385294.
Copy Download .nbib Format: NLM
Who pays and why? Costs, effectiveness, and feasibility of HIV treatment as prevention.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Wilson D, Fraser N.
PMID: 24926029
Clin Infect Dis. 2014 Jul;59:S28-31. doi: 10.1093/cid/ciu300.

Treatment as prevention (TasP) has been added to the toolbox of human immunodeficiency virus (HIV) prevention technologies, and countries are at different stages of TasP deployment. In this article we review some of the cost implications and summarize effectiveness...

Cite
Wilson D, Fraser N. Who pays and why? Costs, effectiveness, and feasibility of HIV treatment as prevention. Clin Infect Dis. 2014;59:S28-31doi: 10.1093/cid/ciu300.
Wilson, D., & Fraser, N. (2014). Who pays and why? Costs, effectiveness, and feasibility of HIV treatment as prevention. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 59S28-31. https://doi.org/10.1093/cid/ciu300
Wilson, David, and Fraser, Nicole. "Who pays and why? Costs, effectiveness, and feasibility of HIV treatment as prevention." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. 59 (2014): S28-31. doi: https://doi.org/10.1093/cid/ciu300
Wilson D, Fraser N. Who pays and why? Costs, effectiveness, and feasibility of HIV treatment as prevention. Clin Infect Dis. 2014 Jul;59:S28-31. doi: 10.1093/cid/ciu300. PMID: 24926029.
Copy Download .nbib Format: NLM
SHARE: a milestone in joint programming for HIV and intimate partner violence.

The Lancet. Global health

Jewkes RK.
PMID: 25539963
Lancet Glob Health. 2015 Jan;3(1):e2-3. doi: 10.1016/S2214-109X(14)70374-2.

No abstract available.

Cite
Jewkes RK. SHARE: a milestone in joint programming for HIV and intimate partner violence. Lancet Glob Health. 2015;3(1):e2-3doi: 10.1016/S2214-109X(14)70374-2.
Jewkes, R. K. (2015). SHARE: a milestone in joint programming for HIV and intimate partner violence. The Lancet. Global health, 3(1), e2-3. https://doi.org/10.1016/S2214-109X(14)70374-2
Jewkes, Rachel K. "SHARE: a milestone in joint programming for HIV and intimate partner violence." The Lancet. Global health vol. 3,1 (2015): e2-3. doi: https://doi.org/10.1016/S2214-109X(14)70374-2
Jewkes RK. SHARE: a milestone in joint programming for HIV and intimate partner violence. Lancet Glob Health. 2015 Jan;3(1):e2-3. doi: 10.1016/S2214-109X(14)70374-2. PMID: 25539963.
Copy Download .nbib Format: NLM
Transmission. Recently infected may not be as infectious as previously thought.

AIDS policy & law

[No authors listed]
PMID: 26094283
AIDS Policy Law. 2015 Apr;30(5):1, 4.

No abstract available.

Cite
Transmission. Recently infected may not be as infectious as previously thought. AIDS Policy Law. 2015;30(5):1, 4
(2015). Transmission. Recently infected may not be as infectious as previously thought. AIDS policy & law, 30(5), 1, 4.
"Transmission. Recently infected may not be as infectious as previously thought." AIDS policy & law vol. 30,5 (2015): 1, 4.
Transmission. Recently infected may not be as infectious as previously thought. AIDS Policy Law. 2015 Apr;30(5):1, 4. PMID: 26094283.
Copy Download .nbib Format: NLM
Propagation of Information About Preexposure Prophylaxis (PrEP) for HIV Prevention Through Twitter.

Health communication

McLaughlin ML, Hou J, Meng J, Hu CW, An Z, Park M, Nam Y.
PMID: 26756069
Health Commun. 2016 Aug;31(8):998-1007. doi: 10.1080/10410236.2015.1027033. Epub 2016 Jan 12.

Previous literature has suggested that examining Twitter messages can be productive for studying how the public shares and spreads health information on social media. Preexposure prophylaxis (PrEP) is a promising approach to HIV prevention, yet there are many issues...

Cite
McLaughlin ML, Hou J, Meng J, et al. Propagation of Information About Preexposure Prophylaxis (PrEP) for HIV Prevention Through Twitter. Health Commun. 2016;31(8):998-1007doi: 10.1080/10410236.2015.1027033.
McLaughlin, M. L., Hou, J., Meng, J., Hu, C. W., An, Z., Park, M., & Nam, Y. (2016). Propagation of Information About Preexposure Prophylaxis (PrEP) for HIV Prevention Through Twitter. Health communication, 31(8), 998-1007. https://doi.org/10.1080/10410236.2015.1027033
McLaughlin, Margaret L, et al. "Propagation of Information About Preexposure Prophylaxis (PrEP) for HIV Prevention Through Twitter." Health communication vol. 31,8 (2016): 998-1007. doi: https://doi.org/10.1080/10410236.2015.1027033
McLaughlin ML, Hou J, Meng J, Hu CW, An Z, Park M, Nam Y. Propagation of Information About Preexposure Prophylaxis (PrEP) for HIV Prevention Through Twitter. Health Commun. 2016 Aug;31(8):998-1007. doi: 10.1080/10410236.2015.1027033. Epub 2016 Jan 12. PMID: 26756069.
Copy Download .nbib Format: NLM
Infection control. HIV and the health care worker (Part 1).

Nursing standard (Royal College of Nursing (Great Britain) : 1987)

Hart S.
PMID: 8398725
Nurs Stand. 1993 Jul 28-Aug 3;7(45):38-9. doi: 10.7748/ns.7.45.38.s43.

Recent press attention on HIV infected health care workers has brought the issue of nurses' and hospitals' responsibility for notifying patients of their HIV status to the fore. In the first of two consecutive articles, the author outlines the...

Cite
Hart S. Infection control. HIV and the health care worker (Part 1). Nurs Stand. 1993;7(45):38-9doi: 10.7748/ns.7.45.38.s43.
Hart, S. (1993). Infection control. HIV and the health care worker (Part 1). Nursing standard (Royal College of Nursing (Great Britain) : 1987), 7(45), 38-9. https://doi.org/10.7748/ns.7.45.38.s43
Hart, S. "Infection control. HIV and the health care worker (Part 1)." Nursing standard (Royal College of Nursing (Great Britain) : 1987) vol. 7,45 (1993): 38-9. doi: https://doi.org/10.7748/ns.7.45.38.s43
Hart S. Infection control. HIV and the health care worker (Part 1). Nurs Stand. 1993 Jul 28-Aug 3;7(45):38-9. doi: 10.7748/ns.7.45.38.s43. PMID: 8398725.
Copy Download .nbib Format: NLM
Japan/United States collaboration in international HIV prevention and care.

Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association

Brown T, Gayle J, Morita K, Brenden N.
PMID: 9070517
J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14:S68-80. doi: 10.1097/00042560-199700002-00012.

At a time when funds for international HIV/AIDS prevention and care appear to be declining, coordinated efforts that maximize resource impact are critical. As leaders in the international community and the world's two largest donors of development assistance, it...

Cite
Brown T, Gayle J, Morita K, et al. Japan/United States collaboration in international HIV prevention and care. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14:S68-80doi: 10.1097/00042560-199700002-00012.
Brown, T., Gayle, J., Morita, K., & Brenden, N. (1997). Japan/United States collaboration in international HIV prevention and care. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 14S68-80. https://doi.org/10.1097/00042560-199700002-00012
Brown, T, et al. "Japan/United States collaboration in international HIV prevention and care." Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association vol. 14 (1997): S68-80. doi: https://doi.org/10.1097/00042560-199700002-00012
Brown T, Gayle J, Morita K, Brenden N. Japan/United States collaboration in international HIV prevention and care. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14:S68-80. doi: 10.1097/00042560-199700002-00012. PMID: 9070517.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 437 entries